Advertisement

Featured Insights

Roger Härtl, MD, in partnership with the Tanzania Neurosurgery Project and Muhimbili Orthopaedic Institute published a paper in Neurosurgical Focus tracking traumatic spinal cord injury patients in East Africa. Their study of 466 patients led to successful follow-ups in 40.6%…

In the last two years, spine and orthopedic leaders made key changes to their work that have paid dividends from moving services in-house to implementing new technologies. The 23 leaders featured in this article are speaking at Becker’s 22nd Annual…

MedVanta’s focus on a direct-to-employer model is expected to improve access to orthopedic care, Louis Levitt, MD, said on an upcoming episode of the “Becker’s Healthcare Podcast.” Dr. Levitt, chief medical officer of MedVanta, discussed the advantage of this model…

House Republicans on March 8 released a funding bill that would let a 2.8% Medicare physician pay cut move forward.  The move has concerned many in healthcare who say cuts could hasten hospital and medical practice closures. Five spine surgeons…

JR Woodall, MD, PhD, has an important role amid a new era of board leadership within U.S. Orthopaedic Partners.

Advertisement

Tariffs have become a key concern for many sectors during President Donald Trump's second term. In February he imposed a 25% tariff on all steel and aluminum imports, a move that is expected to affect medical devices.

Orthopedic, spine, and ambulatory surgery centers (ASCs) are currently navigating a complex landscape marked by volatile tariffs and fluctuating fuel prices. These economic variables significantly impact supply chain stability, procurement costs, and strategic planning. I’ve been asked by many colleagues…

Advertisement